Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Recruiting

Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

NCT05522660

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations
  • Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" Naples, Italy
  • Instituto Oncologico Veneto IRCCS Padova, Italy
  • Santa Maria della Misericordia Hospital Perugia, Italy
  • Istituto Nazionale Tumori "Regina Elena" Roma, Italy
View all 15 locations
View Trial Details
Recruiting

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

NCT06385925

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +21 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Oncology San Antonio, Texas, United States
  • NEXT Virginia Fairfax, Virginia, United States
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
View all 19 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

NCT06010329

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Oncology Physicians Network Healthcare Glendale, California, United States
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University Cancer & Blood Center (UCBC) - Athens Athens, Georgia, United States
View Trial Details
Recruiting

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

NCT06841055

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The University of Alabama at Birmingham Hospital Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Baptist Health Hardin Elizabethtown, Kentucky, United States
  • NYU Langone - NYU Grossman School of Medicine New York, United States
View all 30 locations
View Trial Details
Recruiting

Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC

NCT06536868

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Jincheng General Hospital Jincheng, Shanxi, China
  • Jinzhong third people's hospital Jinzhong, Shanxi, China
  • Second Hospital of Shanxi Medical University Taiyuan, Shanxi, China
  • Shanxi Bethune Hospital Taiyuan, Shanxi, China
View Trial Details
Recruiting

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

NCT05985655

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +34 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START San Antonio San Antonio, Texas, United States
  • START Mountain Region West Valley City, Utah, United States
View all 13 locations
View Trial Details
Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NCT06586957

Conditions
Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
Locations
  • University of Arkansas Medical School Little Rock, Arkansas, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
View all 19 locations
View Trial Details

Related conditions